SAN DIEGO, CA, Mithradote Bio, a biotechnology company developing the first self-administered antidote against drink spiking, announced the closure of an oversubscribed $1 million seed round. The funding round was co-led by Taho Pharma and Vickers Venture Partners.
Read More